Literature DB >> 16949924

Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.

Peng Zhang1, Cunxian Zhang, Jie Hao, C James Sung, M Ruhul Quddus, Margaret M Steinhoff, W Dwayne Lawrence.   

Abstract

Uterine leiomyomas (LMs) and leiomyosarcomas (LMSs), both of smooth muscle origin, sometimes coexist in the same uterus. Little genetic evidence exists concerning the developmental relationship between LM and LMS. Using the X-chromosome inactivation pattern of the human androgen receptor gene, we examined the clonality of LM and LMS. Of the 24 patients with LM, 21 had multiple neoplasms; all were clonal and individual LMs derived from separate clones. Of the 20 patients with LMS, 6 exhibited multiple tumors in the uterus, and 4 of these individuals also harbored coexisting uterine LMs. We found all LMSs to be clonal. Separate tumors showed identical pattern of X inactivation in 4 patients, and in 2 other individuals, multiple LMSs developed from independent clones. Among the 4 patients with LMS and coexisting LM, 3 showed the same pattern of X inactivation in LMS and the adjacent LM. In 2 of the 3 patients, the tumor also exhibited a morphological transition between benign cells in LM and malignant cells in LMS, supporting the possibility of transformation from LM to LMS. One patient displayed different clones in LMS and the coexisting LM, indicating their independent origins. We conclude that (i) both LM and LMS are clonal; (ii) different nodules in multiple LM are of independent origins; (iii) multiple lesions of LMS may be either monoclonal or multiclonal; (iv) most LMSs are solitary lesions and are most likely de novo, but an individual LM may undergo "malignant transformation" to a LMS; and (v) some LMSs and coexisting LMs are of independent origins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949924     DOI: 10.1016/j.humpath.2006.05.005

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  18 in total

1.  Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.

Authors:  Kristie Mozzachio; Alicia B Moore; Grace E Kissling; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2015-12-20       Impact factor: 1.902

2.  Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays.

Authors:  Wayne Bowden; Josh Skorupski; Ertug Kovanci; Aleksandar Rajkovic
Journal:  Mol Hum Reprod       Date:  2009-06-30       Impact factor: 4.025

3.  The study of MED12 gene mutations in uterine leiomyomas from Iranian patients.

Authors:  Samaneh Sadeghi; Mandana Khorrami; Mona Amin-Beidokhti; Maryam Abbasi; Zeeba Kamalian; Shiva Irani; Mirdavood Omrani; Ozra Azmoodeh; Reza Mirfakhraie
Journal:  Tumour Biol       Date:  2015-08-23

Review 4.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

5.  Putative human myometrial and fibroid stem-like cells have mesenchymal stem cell and endometrial stromal cell properties.

Authors:  Amanda L Patterson; Jitu W George; Anindita Chatterjee; Tyler J Carpenter; Emily Wolfrum; David W Chesla; Jose M Teixeira
Journal:  Hum Reprod       Date:  2020-01-01       Impact factor: 6.918

Review 6.  Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma.

Authors:  Masanori Ono; Serdar E Bulun; Tetsuo Maruyama
Journal:  Biol Reprod       Date:  2014-11-05       Impact factor: 4.285

7.  Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo.

Authors:  Ping Yin; Masanori Ono; Molly B Moravek; John S Coon; Antonia Navarro; Diana Monsivais; Matthew T Dyson; Stacy A Druschitz; Saurabh S Malpani; Vanida A Serna; Wenan Qiang; Debabrata Chakravarti; J Julie Kim; Serdar E Bulun
Journal:  J Clin Endocrinol Metab       Date:  2015-02-06       Impact factor: 5.958

8.  Clonality analysis suggests that STK11 gene mutations are involved in progression of lobular endocervical glandular hyperplasia (LEGH) to minimal deviation adenocarcinoma (MDA).

Authors:  Akiko Takatsu; Tsutomu Miyamoto; Chiho Fuseya; Akihisa Suzuki; Hiroyasu Kashima; Akiko Horiuchi; Keiko Ishii; Tanri Shiozawa
Journal:  Virchows Arch       Date:  2013-05-04       Impact factor: 4.064

9.  The expression of selenium-binding protein 1 is decreased in uterine leiomyoma.

Authors:  Peng Zhang; Cunxian Zhang; Xudong Wang; Fang Liu; C James Sung; M Ruhul Quddus; W Dwayne Lawrence
Journal:  Diagn Pathol       Date:  2010-12-09       Impact factor: 2.644

10.  Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas.

Authors:  Ryo Maekawa; Shun Sato; Yoshiaki Yamagata; Hiromi Asada; Isao Tamura; Lifa Lee; Maki Okada; Hiroshi Tamura; Eiichi Takaki; Akira Nakai; Norihiro Sugino
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.